Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity. - Yumiko Okano Tamura; Jun Sugama; Shin-ichi Abe; Yuji Shimizu; Hideki Hirose; Masanori Watanabe (Pharmacology Research & Perspectives, 2023)